Home>
US Stocks>
Rigel Pharmaceuticals

Rigel Pharmaceuticals share price today

(RIGL)

Rigel Pharmaceuticals share price is $17.26 & ₹1,471.76 as on 27 Dec 2024, 2.30 'hrs' IST

$17.26

▲

0.82

(4.99%)

Market is closed - opens 8 PM, 27 Dec 2024

View live Rigel Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Rigel Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Rigel Pharmaceuticals. Get details on the Indian mutual funds that are investing in Rigel Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Rigel Pharmaceuticals's financials.

Rigel Pharmaceuticals share price movements

Today's Low: $15.98
Today's High: $17.37
$17.26
7.42%
Downside
Day's Volatility :7.98%
Upside
0.6%
52 Weeks Low: $7.48
52 Weeks High: $29.82
$17.26
56.64%
Downside
52 Weeks Volatility :74.9%
Upside
42.12%

Rigel Pharmaceuticals Returns

Period	Rigel Pharmaceuticals Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	0.12%	-9.0%	0.0%
6 Months	100.0%	-4.6%	0.0%
1 Year	5.38%	3.0%	0.0%
3 Years	-40.22%	0.0%	-21.1%

Rigel Pharmaceuticals Key Statistics

in dollars & INR

Previous Close	$16.44
Open	$16.44
Today's High	$17.365
Today's Low	$15.98
Market Capitalization	$302.1M
Today's Volume	$490.9K
52 Week High	$29.82
52 Week Low	$7.4843
Revenue TTM	$157.4M
EBITDA	$11.3M
Earnings Per Share (EPS)	$0.27
PE Ratio	63.52
Profit Margin	2.47%
Quarterly Earnings Growth YOY	-0.48%
Return On Equity TTM	-699.05%

How to invest in Rigel Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Rigel Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Rigel Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Rigel Pharmaceuticals or RIGL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Rigel Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Rigel Pharmaceuticals shares which would translate to 0.049 fractional shares of Rigel Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Rigel Pharmaceuticals, in just a few clicks!

Returns in Rigel Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

Rigel Pharmaceuticals investment value today

Current value as on today

₹1,12,966

Returns

₹12,966

(+12.97%)

Returns from Rigel Pharmaceuticals Stock

₹10,641 (+10.64%)

Dollar Returns

₹2,325 (+2.33%)

Indian investors sentiment towards Rigel Pharmaceuticals

247%

Period: Sep 27, 2024 to Dec 26, 2024. Change in 30 Days versus previous period

Search volume for Rigel Pharmaceuticals on INDmoney from India has grown in the last 30 days as on Dec 27, 2024. 247% more investors are searching Rigel Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Rigel Pharmaceuticals

Armistice Capital, LLC
8.72%
BlackRock Inc
8.59%
Morgan Stanley - Brokerage Accounts
8.31%
Amvescap Plc.
5.97%
Vanguard Group Inc
5.59%
Soleus Capital Management, L.P.
5.31%

Analyst Recommendation on Rigel Pharmaceuticals

Buy

58%Buy

41%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Rigel Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Rigel Pharmaceuticals

What analysts predicted

Upside of 81.54%

Current:

$17.26

Target:

$31.33

Insights on Rigel Pharmaceuticals

Price Movement
In the last 7 days, RIGL stock has moved down by -4.5%
Increasing Revenue
Revenue is up for the last 3 quarters, 29.53M → 55.30M (in $), with an average increase of 26.6% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -8.24M → 12.42M (in $), with an average increase of 404.5% per quarter
RIGL vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 10.6%
RIGL vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 67.3%
Price to Sales
ForRIGL every $1 of sales, investors are willing to pay $1.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Rigel Pharmaceuticals Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$44.5M	↑ 892.62%
Net Income	$-70.5M	↓ 9.63%
Net Profit Margin	-158.35%	↑ 1580.99%

	FY19	Y/Y Change
Revenue	$59.3M	↑ 33.2%
Net Income	$-66.5M	↓ 5.58%
Net Profit Margin	-112.24%	↑ 46.11%

	FY20	Y/Y Change
Revenue	$108.6M	↑ 83.21%
Net Income	$-30.4M	↓ 54.33%
Net Profit Margin	-27.98%	↑ 84.26%

	FY21	Y/Y Change
Revenue	$149.2M	↑ 37.39%
Net Income	$-17.9M	↓ 41.05%
Net Profit Margin	-12.0%	↑ 15.98%

	FY22	Y/Y Change
Revenue	$120.2M	↓ 19.43%
Net Income	$-61.6M	↑ 243.84%
Net Profit Margin	-51.23%	↓ 39.23%

	FY23	Y/Y Change
Revenue	$116.9M	↓ 2.79%
Net Income	$-25.1M	↓ 59.27%
Net Profit Margin	-21.47%	↑ 29.76%

	Q2 FY23	Q/Q Change
Revenue	$26.9M	↑ 3.13%
Net Income	$-6.6M	↓ 54.0%
Net Profit Margin	-24.55%	↑ 30.48%

	Q3 FY23	Q/Q Change
Revenue	$28.1M	↑ 4.64%
Net Income	$-5.7M	↓ 13.76%
Net Profit Margin	-20.23%	↑ 4.32%

	Q4 FY23	Q/Q Change
Revenue	$35.8M	↑ 27.22%
Net Income	$737.0K	↓ 112.95%
Net Profit Margin	2.06%	↑ 22.29%

	Q1 FY24	Q/Q Change
Revenue	$29.5M	↓ 17.48%
Net Income	$-8.2M	↓ 1219.0%
Net Profit Margin	-27.92%	↓ 29.98%

	Q2 FY24	Q/Q Change
Revenue	$36.8M	↑ 24.74%
Net Income	$-1.0M	↓ 87.51%
Net Profit Margin	-2.8%	↑ 25.12%

	Q3 FY24	Q/Q Change
Revenue	$55.3M	↑ 50.12%
Net Income	$12.4M	↓ 1305.92%
Net Profit Margin	22.46%	↑ 25.26%

	FY18	Y/Y Change
Profit	$44.2M	↓ 205.83%

	FY19	Y/Y Change
Profit	$58.4M	↑ 32.02%

	FY20	Y/Y Change
Profit	$107.7M	↑ 84.52%

	FY21	Y/Y Change
Profit	$148.2M	↑ 37.53%

	FY22	Y/Y Change
Profit	$118.5M	↓ 20.02%

	FY23	Y/Y Change
Profit	$109.8M	↓ 7.36%

	Q2 FY23	Q/Q Change
Profit	$25.8M	↑ 2.86%

	Q3 FY23	Q/Q Change
Profit	$26.9M	↑ 4.09%

	Q4 FY23	Q/Q Change
Profit	$32.0M	↑ 19.12%

	Q1 FY24	Q/Q Change
Profit	$27.5M	↓ 14.04%

	Q2 FY24	Q/Q Change
Profit	$34.0M	↑ 23.72%

	Q3 FY24	Q/Q Change
Profit	$47.3M	↑ 38.92%

	FY18	Y/Y Change
Operating Cash Flow	$-58.8M	↓ 24.15%
Investing Cash Flow	$25.0M	↓ 228.2%
Financing Cash Flow	$71.9M	↓ 38.91%

	FY19	Y/Y Change
Operating Cash Flow	$-41.5M	↓ 29.44%
Investing Cash Flow	$-23.7M	↓ 194.76%
Financing Cash Flow	$11.4M	↓ 84.19%

	FY20	Y/Y Change
Operating Cash Flow	$-52.2M	↑ 25.72%
Investing Cash Flow	$47.5M	↓ 300.65%
Financing Cash Flow	$12.6M	↑ 10.61%

	FY21	Y/Y Change
Operating Cash Flow	$5.9M	↓ 111.26%
Investing Cash Flow	$-80.0M	↓ 268.62%
Financing Cash Flow	$62.7M	↑ 398.57%

	FY22	Y/Y Change
Operating Cash Flow	$-73.8M	↓ 1354.81%
Investing Cash Flow	$72.8M	↓ 190.93%
Financing Cash Flow	$6.6M	↓ 89.55%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$5.9M	↓ 245.56%
Investing Cash Flow	$3.0M	↑ 282.24%
Financing Cash Flow	$-373.0K	↓ 101.95%

Rigel Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Rigel Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Rigel Pharmaceuticals Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Rigel Pharmaceuticals Inc	-41.03%	100.0%	5.38%	-40.22%	-21.71%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.02%	-18.97%	11.91%	91.19%
Biontech Se	-3.72%	42.02%	7.95%	-52.72%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	0.1%	24.29%	44.19%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-12.92%	-0.27%	83.92%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Rigel Pharmaceuticals Inc	63.52	63.52	-0.1	0.24	-6.99	0.05	NA	-0.83
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Rigel Pharmaceuticals Inc	Buy	$302.1M	-21.71%	63.52	2.47%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Rigel Pharmaceuticals

rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.

Organization	Rigel Pharmaceuticals
Employees	147
CEO	Mr. Raul R. Rodriguez
Industry	Health Technology

Management People of Rigel Pharmaceuticals

Name	Title
Mr. Raul R. Rodriguez	President, CEO & Director
Mr. Dean L. Schorno CPA	Executive VP & CFO
Mr. Raymond J. Furey J.D.	Executive VP, General Counsel & Corporate Secretary
Mr. David A. Santos	Executive VP & Chief Commercial Officer
Ms. Julie Patel	Senior VP of Human Resources
Dr. Esteban S. Masuda Ph.D.	Executive Vice President of Research
Mr. Joseph Lasaga	Executive VP & Chief Business Officer
Dr. Lisa Rojkjaer M.D.	Executive VP & Chief Medical Officer
Mr. Tarek Sallam	Vice President of Marketing

Important FAQs about investing in Rigel Pharmaceuticals from India :

What is Rigel Pharmaceuticals share price today?

Rigel Pharmaceuticals share price today stands at $17.26, Open: $16.44 ; Previous Close: $16.44 ; High: $17.37 ; Low: $15.98 ; 52 Week High: $29.82 ; 52 Week Low: $7.48. The stock opens at $16.44, after a previous close of $16.44. The stock reached a daily high of $17.37 and a low of $15.98, with a 52-week high of $29.82 and a 52-week low of $7.48.

Can Indians buy Rigel Pharmaceuticals shares?

Yes, Indians can invest in the Rigel Pharmaceuticals (RIGL) from India.

With INDmoney, you can buy Rigel Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Rigel Pharmaceuticals at zero transaction cost.

How can I buy Rigel Pharmaceuticals shares from India?

It is very easy to buy Rigel Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Rigel Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Rigel Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Rigel Pharmaceuticals stocks?

To start investing in Rigel Pharmaceuticals, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.